MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-06-0010293
Mabel Pharmaceuticals Private Limited - pharma in Haridwar, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹23.88 Lakh
▼ 52% YoY
Net profit · FY 2024
₹34,898
Net margin 1.5%
EBITDA · FY 2024
₹1.22 Lakh
EBITDA margin 5.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Mabel Pharmaceuticals Private Limited
Data last updated:
Mabel Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2016PTC007023. Its GSTIN is 05AAKCM4435A1ZV (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Naresh Kumar Pant and Naveen Chandra Pant.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S439 Shivalik Nagar Kalaster S209 Se 519 Bahadrabad, Haridwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.88 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net profit of ₹34,898 (net margin 1.5%) and EBITDA of ₹1.22 Lakh (EBITDA margin 5.1%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 1% over five years.
The company is associated with 1 brand: Mabel Pharmaceuticals. As per MCA filings, the company has open charges of ₹5 Lakh on record.
Mabel Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0010293). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mabelpharmaceuticals.com.
Company details
CIN U74999UR2016PTC007023
Registration Number 007023
Incorporation Date 27 April 2016
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-06-0010293
Recognitions & Rankings of Mabel Pharmaceuticals
Contact details
Mabel Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its website is mabelpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS439 Shivalik Nagar Kalaster S209 Se 519 Bahadrabad, Haridwar, Uttarakhand, India – 249403
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mabel Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Mabel Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mabel Pharmaceuticals operates one associated brand: Mabel Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and services focused on global healthcare in India. | mabelpharmaceuticals.com |
Business activity
The main business activity of Mabel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mabel Pharmaceuticals Private Limited, buy the company report.
Financials of Mabel Pharmaceuticals Private Limited
FY 2025 filings availableMabel Pharmaceuticals Private Limited reported revenue of ₹23.88 Lakh (down 52% YoY) for FY 2024.
Revenue · FY 2024
₹23.88 Lakh ▼ 52%
Net profit · FY 2024
₹34,898 margin 1.5%
EBITDA · FY 2024
₹1.22 Lakh margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 52%
3 years · compounded
▲ 11%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 13%
5 years · compounded
▲ 4%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 52% fall in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,898 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mabel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mabel Pharmaceuticals Private Limited
Mabel Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kumar Pant | Director | 20 Nov 2023 | 2 Years 11 Months | Current |
| Naveen Chandra Pant | Director | 27 Apr 2016 | 10 Years 6 Months | Current |
| Kamal Kishor | Director | 27 Apr 2016 | 10 Years 6 Months | Current |
Auditor
Mabel Pharmaceuticals Private Limited is audited by ASHISH SWATI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHISH SWATI & ASSOCIATES | FY 2018 | 023750N |
Shareholding
The shareholding of Mabel Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mabel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Nov 2017 | 100138297 | State Bank of India | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mabel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mabel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mabel Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAKCM4435A1ZV | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mabel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mabel Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Naresh Kumar Pant was appointed as Director on 20 Nov 2023.
AGM
Mabel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mabel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Naresh Kumar Pant was appointed as Director.
Ceased
Rajeev Sharma ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 5.00 Lakh with Charge ID 100138297 was registered on 10 Nov 2017.
Appointed
Kamal Kishor was appointed as Director.
Appointed
Naveen Chandra Pant was appointed as Director.
Incorporation
27 Apr 2016
Mabel Pharmaceuticals Private Limited was registered on 27 Apr 2016 with Roc Uttarakhand & aged 10 years 6 months as per MCA records.
Frequently asked questions
Mabel Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2016 (10+ years old) and is registered under CIN U74999UR2016PTC007023.
Mabel Pharmaceuticals has 3 current directors:
- Naresh Kumar Pant - Director
- Naveen Chandra Pant - Director
- Kamal Kishor - Director
The latest financial statements of Mabel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Mabel Pharmaceuticals is 05AAKCM4435A1ZV, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Mabel Pharmaceuticals is U74999UR2016PTC007023. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mabel Pharmaceuticals was incorporated on 27 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Naresh Kumar Pant was appointed as Director on 20 Nov 2023. Rajeev Sharma ceased to be Director on 01 Apr 2019. Kamal Kishor was appointed as Director on 27 Apr 2016. Mabel Pharmaceuticals has 4 board changes on record in total.
Yes, Mabel Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0010293).
Mabel Pharmaceuticals can be reached through the website mabelpharmaceuticals.com. Its registered office is in Haridwar, Uttarakhand, India.
The registered office of Mabel Pharmaceuticals is at S439 Shivalik Nagar Kalaster S209 Se 519 Bahadrabad, Haridwar, Uttarakhand, India – 249403.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages